Catalyst Event
Bristol-Myers Squibb Co (BMY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
6/11/2026, 12:00:00 AM
Competitor Takeda announced its experimental drug zasocitinib demonstrated superiority over BMY's Sotyktu in a head-to-head Phase 3 trial for psoriasis, potentially impacting Sotyktu's market share. This significant competitive threat is estimated to have a 10% or greater price impact.
Korean Translation
경쟁사 다케다, 건선 치료제 후보물질 자소시티닙(zasocitinib)이 BMY의 소틱투(Sotyktu)와의 직접 비교 3상 임상시험에서 우월성을 입증했다고 발표함. 이는 소틱투의 시장 점유율에 중대한 위협이 되어 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Costco Wholesale Corp (COST) · Earnings Release
Q4 2026 earnings release scheduled. Low importance estimated as it is a routine quarterly update.
9/24/2026, 12:00:00 AM
NetApp Inc (NTAP) · Earnings Release
NetApp is scheduled to announce its financial results for the first quarter of fiscal year 2027 on September 2, 2026, as per the company's investor relations page. Market impact is estimated at 5% based on historical earnings volatility, scheduled.
9/2/2026, 12:00:00 AM
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA is scheduled to release its Q2 2027 fiscal year earnings report after the market closes on August 26, 2026, followed by a conference call; high price impact (>10%) is expected based on historical earnings volatility scheduled
8/26/2026, 12:00:00 AM
Snowflake Inc (SNOW) · Earnings Release
Snowflake is expected to announce its financial results for the second quarter of fiscal year 2027 on 2026-08-26, scheduled. Earnings releases for high-growth tech stocks typically result in price moves exceeding 5%.
8/26/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart is scheduled to release its Q2 FY2027 earnings results on August 20, 2026, before the market opens; Medium importance is estimated as earnings reports often lead to price adjustments expected.
8/20/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Target is scheduled to report Q2 2026 earnings on August 19, 2026; analysts forecast EPS of $2.21-$2.26. Medium importance is estimated based on historical earnings volatility exceeding 5% expected.
8/19/2026, 12:00:00 AM